drugset / Trial / NCT01279499

Sevoflurane Versus Intravenous Anaesthetic Agents in Morbid Obese Patients

NCT01279499

Phase 2/3 Unknown 100 enrolled University of Patras
RandomizedParallel-groupTriple-blindTreatment

Summary

The objective of this prospective randomized clinical study was to compare anesthesia, in morbidly obese patents (BMI \>50) who underwent BPD-RYGBP with either sevoflurane or propofol with remifentanyl.

Timeline

Start
2010-04
Primary completion
2011-06
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Comparator Propofol Small molecule 150 ug/kg Intravenous
Comparator Propofol Small molecule 300 ug/kg Intravenous
Comparator Remifentanil Small molecule 0.1 ug/kg Intravenous
Comparator Remifentanil Small molecule 1 ug/kg Intravenous
Comparator Sevoflurane Other / unclassified Inhaled

Indications